• Explore /
  • Poster
  • / RIA: Randomized phase II study comparing induction (I) mFOLFOX6 with or without aflibercept followed by chemoradiation (CRT) and total mesorectal excision (TME) in high risk-rectal cancer. GEMCAD 14-02 trial.

RIA: Randomized phase II study comparing induction (I) mFOLFOX6 with or without aflibercept followed by chemoradiation (CRT) and total mesorectal excision (TME) in high risk-rectal cancer. GEMCAD 14-02 trial.

Abstract Poster

Authors

null

Carlos Fernandez-Martos

Instituto Valenciano De Oncologia, Valencia, Spain

Carlos Fernandez-Martos , Carles Pericay , Ferran Losa , Rocio Garcia-Carbonero , Laura Layos , Nuria Rodriguez Salas , Marta Martin , Vicente Alonso , Ruth Vera , Javier Gallego , Jaume Capdevila , Antonieta Salud , Miquel Nogue , Juan Maurel , Inmaculada Guasch , Clara Montagut Viladot , Carlos López-López , MªÁngeles Cañas , Ismael Macias Declara , Xabier García-Albéniz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Local-Regional Disease

Clinical Trial Registration Number

NCT02340949

Citation

J Clin Oncol 36, 2018 (suppl; abstr 3518)

DOI

10.1200/JCO.2018.36.15_suppl.3518

Abstract #

3518

Poster Bd #

11

Abstract Disclosures

Similar Posters

First Author: Carlos Fernandez-Martos

First Author: Carlos Fernandez-Martos

First Author: Kimberly Perez

First Author: D. Helbling